Imaging Startup Braid Health Launches Radiologist 2nd Opinion Service Charging $199 per Read

Why It Matters

By slashing price and eliminating referral hurdles, Braid expands patient access to expert imaging reviews, pressuring traditional radiology pathways and lowering out‑of‑pocket costs.

Key Takeaways

• Braid Health charges $199 per radiology second opinion.
• Service covers MRI, CT, ultrasound, and X‑ray re‑reads.
• Turnaround delivered within days, faster than hospital weeks.
• Over 650,000 platform users benefit from AI‑driven imaging tools.
• Traditional second opinions cost $500‑$1,500, often require referrals.

Pulse Analysis

Braid Health’s $199 online radiology second‑opinion service marks a notable shift in tele‑imaging, leveraging the company’s AI‑powered platform to streamline the review process. Patients simply upload DICOM files, and board‑certified radiologists perform a sequence‑by‑sequence re‑read, returning annotated reports in days rather than weeks. The pricing undercuts conventional hospital‑based second opinions, which can exceed $1,500 and require cumbersome referrals, positioning Braid as a cost‑effective alternative for consumers seeking diagnostic confidence before surgery or treatment.

The launch arrives amid a broader telehealth surge, where digital health startups are capitalizing on patient demand for convenient, transparent care. Braid’s existing user base of over 650,000 demonstrates market traction for AI‑enhanced imaging workflows, and its prior $9 million funding round and FDA clearance lend credibility to its clinical offerings. By removing insurance‑mediated barriers, the service empowers patients who may be unaware of their right to a second opinion, potentially driving higher utilization and prompting providers to reconsider referral practices.

Looking ahead, Braid’s model could influence radiology economics by encouraging more direct‑to‑consumer services and prompting hospitals to reassess pricing structures. Integration with electronic health records and partnerships with health systems may expand its reach, while competition from other digital radiology platforms could spur further innovation in speed, AI accuracy, and pricing. If adoption scales, the service may become a standard pre‑procedure check, reshaping how patients and clinicians approach diagnostic certainty.